Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets

Proteomics
Chary López-PedreraFrancisco Velasco

Abstract

The main goal of this study was to analyze, using proteomic techniques, changes in protein expression of acute myeloid leukemia (AML) cells that could give insights into a better early prognosis for tumor pathophysiology. Proteomic analysis of different subtypes of AML cells was carried out using 2-DE and MALDI-TOF PMF analysis. Proteins identified as more significantly altered between the different AMLs belonged to the group of suppressor genes, metabolic enzymes, antioxidants, structural proteins and signal transduction mediators. Among them, seven identified proteins were found significantly altered in almost all the AML blast cells analyzed in relation to normal mononuclear blood cells: alpha-enolase, RhoGDI2, annexin A10, catalase, peroxiredoxin 2, tromomyosin 3, and lipocortin 1 (annexin 1). These differentially expressed proteins are known to play important roles in cellular functions such as glycolysis, tumor suppression, apoptosis, angiogenesis and metastasis, and they might contribute to the adverse evolution of the disease. Proteomic analysis has identified for the first time novel proteins that may either help to form a differential prognosis or be used as markers for disease outcome, thus providing potential new ta...Continue Reading

References

Mar 1, 1994·Trends in Pharmacological Sciences·R J Flower, N J Rothwell
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N L HarrisC D Bloomfield
Dec 23, 1999·The Journal of Biological Chemistry·L C AlldridgeC E Bryant
Mar 4, 2000·Somatic Cell and Molecular Genetics·V ShahG L Prasad
Jul 28, 2001·Seminars in Hematology·A K Burnett
Sep 12, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·S L GrazianoJ A Kern
May 29, 2002·Oncogene·Blanca Scheijen, James D Griffin
Aug 27, 2002·Annual Review of Genomics and Human Genetics·Louise M Kelly, D Gary Gilliland
Sep 12, 2002·Expert Opinion on Therapeutic Targets·Gerhard BehreSheo M Singh
Sep 28, 2002·American Journal of Hematology·Hiroshi FujiwaraChuwa Tei
Nov 25, 2003·Hematology·Bob LöwenbergMartin S Tallman
May 5, 2004·Seminars in Oncology·Elliott F Winton, Amelia A Langston
Nov 25, 2004·Hematology·Richard M StoneMikkael A Sekeres
Jan 14, 2005·International Journal of Hematology·Hiroyuki Mano

❮ Previous
Next ❯

Citations

Aug 21, 2012·Antioxidants & Redox Signaling·Mary E IrwinJoya Chandra
Nov 3, 2012·Journal of Biomedicine & Biotechnology·Angels Díaz-RamosRoser López-Alemany
Jul 16, 2013·Journal of Hematology & Oncology·Maria BraoudakiFotini Tzortzatou-Stathopoulou
Mar 9, 2010·PloS One·Brady G Miller, John A Stamatoyannopoulos
May 30, 2013·Cellular and Molecular Life Sciences : CMLS·Nina QuiskampUrsula Rescher
Mar 25, 2014·Current Hematologic Malignancy Reports·Bhavana Bhatnagar, Ramiro Garzon
Aug 2, 2012·Journal of Proteomics·Magdalena LuczakMarek Figlerowicz
Apr 10, 2012·Nature Chemical Biology·Chuan-Xu LiuGuo-Qiang Chen
Oct 12, 2010·Leukemia & Lymphoma·Maria BraoudakiFotini Tzortzatou-Stathopoulou
Jun 26, 2012·Experimental Cell Research·Chuan-Xu LiuGuo-Qiang Chen
May 12, 2009·Leukemia Research·Yuko IsekiShinichiro Takahashi
Oct 28, 2008·Biochimica Et Biophysica Acta·Fabien RondepierreFrançoise Degoul
Mar 24, 2007·Experimental Hematology·Kanokporn Noy RithidechSanford R Simon
Jan 26, 2011·The FEBS Journal·Michela CapelloFrancesco Novelli
Jun 10, 2014·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Jung Ho KimGyeong Hoon Kang
Oct 19, 2010·Journal of Oncology·Rémi FiancetteYves Denizot
Apr 23, 2009·Molecular Oncology·Kewal K Jain
Sep 15, 2016·Technology in Cancer Research & Treatment·Xin ZhouBing-Dong Zhu
Feb 17, 2017·The Journal of Experimental Medicine·Amelie V GuitartKamil R Kranc
Dec 5, 2019·International Journal of Molecular Sciences·Jonathan R SillarMatthew D Dun
Jan 22, 2011·Electrophoresis·Jitendra Kumar KanaujiyaArun Kumar Trivedi
Jun 23, 2018·Leukemia·Kim R KampenKim De Keersmaecker
Dec 26, 2018·Oxidative Medicine and Cellular Longevity·Cecilia PrataDiana Fiorentini
Jan 28, 2021·Critical Reviews in Analytical Chemistry·Negin Fasih RamandiHassan Y Aboul-Enein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.